Thromb Haemost 1989; 61(03): 343-347
DOI: 10.1055/s-0038-1646592
Original Article
Schattauer GmbH Stuttgart

The Use of DNA Amplification for Genetic Counselling Related Diagnosis in Haemophilia B

Authors

  • T C Tsang

    1   The Paediatric Research Unit, Division of Medical and Molecular Genetics, United Medical and Dental Schools of Guy’s and St Thomas’s Hospitals, Guy’s Hospital Tower, London, United Kingdom
  • D R Bentley

    1   The Paediatric Research Unit, Division of Medical and Molecular Genetics, United Medical and Dental Schools of Guy’s and St Thomas’s Hospitals, Guy’s Hospital Tower, London, United Kingdom
  • I M Nilsson

    2   The Department of Coagulation, University Hospital, Malmö, Sweden
  • F Giannelli

    1   The Paediatric Research Unit, Division of Medical and Molecular Genetics, United Medical and Dental Schools of Guy’s and St Thomas’s Hospitals, Guy’s Hospital Tower, London, United Kingdom
Further Information

Publication History

Received 04 November 1988

Accepted 16 January 1989

Publication Date:
24 July 2018 (online)

Preview

Summary

A single base pair variation in the coding sequence of coagulation factor IX produces a protein polymorphism detectable with monoclonal antibodies and a restriction fragment length polymorphism (RFLP). This allows carrier and prenatal diagnoses in 48% of Caucasian families segregating for haemophilia B. However, this RFLP cannot be detected by standard Southern blotting, while the antibody assay may grve equivocal results in some females and can only allow prenatal diagnoses on second trimester fetal blood samples. We show that, using the polymerase chain reaction, the polymorphic DNA segment can be amplified and directly tested for the presence of the alternative sequences by a non-radioactive procedure that has the advantage of speed (1–2 days), partial automation and applicability to first trimester diagnoses. We also show that the method gives results on a single drop of dried blood.